Iron Chelation Therapy as a Modality of Management.

Aydinok, Yesim

Aydinok, Yesim.

Affiliation

Aydinok Y; Department of Pediatric Hematology and Oncology, Ege University Children's Hospital, Bornova, Izmir 35100, Turkey. Electronic address: yesim.aydinok@yahoo.com.

Hematol Oncol Clin North Am ; 32(2): 261-275, 2018 04.

Article in En | MEDLINE | ID: mdl-29458731

Subject(s)

Iron Chelating Agents/therapeutic use; Iron Overload/drug therapy; Iron Overload/etiology; Thalassemia/complications; Biomarkers; Blood Transfusion; Chelation Therapy; Endocrine System Diseases/drug therapy; Endocrine System Diseases/etiology; Endocrine System Diseases/metabolism; Endocrine System Diseases/prevention & control; Humans; Iron/metabolism; Iron Overload/diagnosis; Iron Overload/metabolism; Liver/diagnostic imaging; Liver/metabolism; Liver/pathology; Magnetic Resonance Imaging; Thalassemia/metabolism; Thalassemia/therapy

Key words

Cardiac iron; Chelation; Liver iron concentration; Non-transfusion dependent thalassemia; Serum ferritin; Thalassemia intermedia; Thalassemia major; Transfusion-dependent thalassemia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Thalassemia / Iron Chelating Agents / Iron Overload Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Hematol Oncol Clin North Am Year: 2018 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google